Cargando…

Transmitted Minority Drug-Resistant HIV Variants: A New Epidemic?

Steven Deeks discusses a new study that investigates the prevalence and clinical implications of transmitted minority drug-resistant HIV variants.

Detalles Bibliográficos
Autor principal:	Deeks, Steven G
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2488200/ https://www.ncbi.nlm.nih.gov/pubmed/18666826 http://dx.doi.org/10.1371/journal.pmed.0050164

Ejemplares similares

Fact and Fiction about 1%: Next Generation Sequencing and the Detection of Minor Drug Resistant Variants in HIV-1 Populations with and without Unique Molecular Identifiers
por: Zhou, Shuntai, et al.
Publicado: (2020)

Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications
por: Husain, Aliabbas A., et al.
Publicado: (2021)

Epidemiological metrics and benchmarks for a transition in the HIV epidemic
por: Ghys, Peter D., et al.
Publicado: (2018)

Transmitted Drug Resistance in Persons with Acute/Early HIV-1 in San Francisco, 2002-2009
por: Jain, Vivek, et al.
Publicado: (2010)

The expanding epidemic of HIV-1 in the Russian Federation
por: Beyrer, Chris, et al.
Publicado: (2017)

HIV Drug-resistant Strains as Epidemiologic Sentinels
por: Sánchez, María S., et al.
Publicado: (2006)

A Paradigm Shift to Prevent HIV Drug Resistance
por: Bangsberg, David R
Publicado: (2008)

Hidden Epidemic of Macrolide-resistant Pneumococci
por: Klugman, Keith P., et al.
Publicado: (2005)

Introduction of Phylodynamics for Controlling the HIV/AIDS Epidemic in Korea
por: Bae, Jong-Myon
Publicado: (2018)

Graying of the HIV epidemic: a challenge for inpatient medicine providers
por: Harris, Ché Matthew, et al.
Publicado: (2015)

Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic
por: Pineda-Peña, Andrea-Clemencia, et al.
Publicado: (2014)

Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement
por: Marrazzo, Jeanne M., et al.
Publicado: (2018)

1282. Detection of HIV Transmitted Drug Resistance by Next-Generation Sequencing in a CRF01_AE Predominant Epidemic
por: Salvana, Edsel Maurice, et al.
Publicado: (2018)

Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection
por: Stekler, Joanne D., et al.
Publicado: (2011)

Persistence of HIV-1 Transmitted Drug Resistance Mutations
por: Castro, Hannah, et al.
Publicado: (2013)

High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea
por: Lavu, Evelyn, et al.
Publicado: (2017)

The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model
por: Kendall, Emily A., et al.
Publicado: (2015)

Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?
por: Friedman, Samuel R., et al.
Publicado: (2023)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
por: Bennett, Diane E., et al.
Publicado: (2009)

Sexual Health and Sexually Transmitted Infections in the North American Arctic
por: Law, Dionne Gesink, et al.
Publicado: (2008)

Transmitted drug resistance in patients with acute/recent HIV infection in Brazil
por: Ferreira, Ana Cristina G., et al.
Publicado: (2017)

National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2011)

Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity
por: Pingen, Marieke, et al.
Publicado: (2014)

Towards control of the global HIV epidemic: Addressing the middle-90 challenge in the UNAIDS 90–90–90 target
por: Iwuji, Collins, et al.
Publicado: (2017)

Public health information for minority linguistic communities
por: Di Carlo, Pierpaolo, et al.
Publicado: (2022)

A combination approach of behavioural and biomedical interventions for prevention of sexually transmitted infections
por: Toskin, Igor, et al.
Publicado: (2020)

The vaginal microbiome and sexually transmitted infections are interlinked: Consequences for treatment and prevention
por: van de Wijgert, Janneke H. H. M.
Publicado: (2017)

The statistics of epidemic transitions
por: Drake, John M., et al.
Publicado: (2019)

Stalking the next epidemic
por: Shah, Sonia
Publicado: (2011)

Evaluating epidemic forecasts in an interval format
por: Bracher, Johannes, et al.
Publicado: (2021)

HIV epidemic among men who have sex with men in the Czech Republic, 2016: high time for targeted action
por: Mravčík, Viktor, et al.
Publicado: (2017)

Cosmetic labiaplasty on minors: a review of current trends and evidence
por: Kalampalikis, Andreas, et al.
Publicado: (2021)

Antimicrobial Drug Resistance, Regulation, and Research
por: Metlay, Joshua P., et al.
Publicado: (2006)

Toward “Inclusifying” the Underrepresented Minority in STEM Education Research
por: Bhatti, Haider Ali
Publicado: (2021)

The role of sexually transmitted infections in male circumcision effectiveness against HIV – insights from clinical trial simulation
por: Desai, Kamal, et al.
Publicado: (2006)

Correction: National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2012)

Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011
por: Jahanbakhsh, Fatemeh, et al.
Publicado: (2013)

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group
por: Frentz, Dineke, et al.
Publicado: (2014)

Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021
por: Su, Yifan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gbdbi5feslepuiuobu3qgon44t